COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Core Valve Low Risk

Purpose of Study

Evaluate the safety and effectiveness of the Medtronic Transcatheter Aortic Valve Replacement System in patients with severe aortic stenosis at low risk for Surgical Aortic Valve Replacement

Trial Status

In follow up

Eligibility Criteria

Severe aortic stenosis and < 3% predicted risk of mortality at 30 days for Surgical Aortic Valve Replacement

Duration of Participation

Approximately 5-10 years

Contact Name: Kendra Tuttle, RN

Contact Phone: 515-235-5102

Contact Email: ktuttle@iowaheart.com